Narcolepsy Med Shows Early Promise for Adult ADHD
Solriamfetol may be a safe and effective nonstimulant treatment for adults with ADHD, results of a small, double-blind, placebo-controlled pilot study suggest
Stay updated with breaking news from Adverse Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Solriamfetol may be a safe and effective nonstimulant treatment for adults with ADHD, results of a small, double-blind, placebo-controlled pilot study suggest
Patients with idiopathic pulmonary fibrosis who required dose reductions had similar all-cause mortality and death rates vs patients on the full dose.
Struggles with housing and food security as well as concerns about medication side effects appear to exacerbate a lack of medication adherence.
A 10-year follow-up analysis found that partial-breast and reduced-dose radiation therapy were noninferior to full-breast radiation therapy among women with early breast cancer.
Those who discontinued the "twincretin" drug after 36 weeks regained weight but still maintained some weight loss at 1 year.